Evidence map›Paper›PMID 21900603›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2011

Myeloid-specific estrogen receptor alpha deficiency impairs metabolic homeostasis and accelerates atherosclerotic lesion development.

Vicent Ribas, Brian G Drew, Jamie A Le, Teo Soleymani, Pedram Daraei, Daniel Sitz, Laila Mohammad, Darren C Henstridge, Mark A Febbraio, Sylvia C Hewitt and 3 more

Erratum issued Registry-linked trialAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT01686828 (Androgen-mediated Pathways in the Regulation of Insulin Sensitivity in Men), which is not on this map. Cited by 113 papers.

0numbers the graph read from it
0cells of the map it votes in
113citing papers in PubMed
8.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01686828 phase1 / phase2completednot on this mapstarted 2013, after this paper: background citation

Androgen-mediated Pathways in the Regulation of Insulin Sensitivity in Men

TypeinterventionalSponsorUniversity of WashingtonRan2013 to 2017Enrolled53ConditionsInsulin Resistance, Type 2 Diabetes Mellitus, Obesity, Androgen DeficiencyArmsAcyline, Testosterone 1.62% gel, Letrozole, Placebo gel (for Testosterone 1.62% gel), Placebo pill (for Letrozole)
3 · Its place in the literature

Who cites it

113 citing papers in PubMed, 174 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Metabolic Messengers: testosterone.Nature metabolism · 2026
    Review
  7. Review
  8. Metabolic Messengers: oestradiol.Nature metabolism · 2025
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

53 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Vicent RibasDavid Geffen School of Medicine, Department of Medicine, Division of Endocrinology, Diabetes and Hypertension, University of California, Los Angeles, CA 90095-7073, USA.
Brian G Drew
Jamie A Le
Teo Soleymani
Pedram Daraei
Daniel Sitz
Laila Mohammad
Darren C Henstridge
Mark A Febbraio
Sylvia C Hewitt
Kenneth S Korach
Steven J Bensinger
Andrea L Hevener
University of California, Los Angeles · USBaker Heart and Diabetes Institute · AUInstitute for Molecular Medicine · USNational Institute of Environmental Health Sciences · USNational Institutes of Health · US

Funding

Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PETER J TONTONOZ · 2003 to 2026
$40.4M
Chemical Receptor Interactions In Reproduction And Hormonal ToxicityZIAES070065 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI KORACH, KENNETH S · 2009 to 2019
$29.6M
Chemical Receptor Interactions Reproduction/HormonalZ01ES070065 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI KORACH, KENNETH S · 1985 to 2008
$5.0M
ERalpha and the metabolic syndromeR01DK089109 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HEVENER, ANDREA L · 2011 to 2014
$1.4M
The Role of PPARgamma Expression on Insulin ActionK01DK060484 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HEVENER, ANDREA L · 2002 to 2006
$542k
The impact of PPAR-gamma and estrogen receptor crosstalk on insulin actionR21DK073227 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HEVENER, ANDREA L · 2006 to 2007
$419k
Intramural NIH HHS Z01 ES070065NIDDK NIH HHS DK060484NIDDK NIH HHS DK063491NIDDK NIH HHS DK073227NIDDK NIH HHS K01 DK060484NIDDK NIH HHS P30 DK063491NIDDK NIH HHS R01 DK089109NIDDK NIH HHS R21 DK073227
6 · The paper itself

Abstract

ERα is expressed in macrophages and other immune cells known to exert dramatic effects on glucose homeostasis. We investigated the impact of ERα expression on macrophage function to determine whether hematopoietic or myeloid-specific ERα deletion manifests obesity-induced insulin resistance in mice. Indeed, altered plasma adipokine and cytokine levels, glucose intolerance, insulin resistance, and increased adipose tissue mass were observed in animals harboring a hematopoietic or myeloid-specific deletion of ERα. A similar obese phenotype and increased atherosclerotic lesion area was displayed in LDL receptor-KO mice transplanted with ERα(-/-) bone marrow. In isolated macrophages, ERα was necessary for repression of inflammation, maintenance of oxidative metabolism, IL-4-mediated induction of alternative activation, full phagocytic capacity in response to LPS, and oxidized LDL-induced expression of ApoE and Abca1. Furthermore, we identified ERα as a direct regulator of macrophage transglutaminase 2 expression, a multifunctional atheroprotective enzyme. Our findings suggest that diminished ERα expression in hematopoietic/myeloid cells promotes aspects of the metabolic syndrome and accelerates atherosclerosis in female mice.

Indexed as

HomeostasisAdiposityAnimalsAtherosclerosisBone MarrowEstrogen Receptor alphaFemaleGlucoseInsulin ResistanceInterleukin-4MacrophagesMiceMice, Inbred C57BLMice, KnockoutEstrogen Receptor alphaGlucoseInterleukin-4

Identifiers

PMID21900603
PMCPMC3182726
OpenAlexW2037725361

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.